Sunday, November 22, 2026
My Cannabis Art
48.65 °f
Lansing
41.20875 ° Mon
31.76125 ° Tue
  • Login
  • Register
  • Home
    • About Us
    • Affiliate Disclosure
    • Privacy Policy
    • Terms & Disclaimer
  • News
  • Strains
  • Reviews
  • Seeds
  • The Grow Room
    • Start Here
    • Growing Cannabis
    • Strains & Genetics
    • Autoflowers
    • Indoor Growing
    • Grow Equipment
    • Grow Journals
    • Grow Problems
    • Harvest, Dry & Cure
No Result
View All Result
My Cannabis Art
  • Home
    • About Us
    • Affiliate Disclosure
    • Privacy Policy
    • Terms & Disclaimer
  • News
  • Strains
  • Reviews
  • Seeds
  • The Grow Room
    • Start Here
    • Growing Cannabis
    • Strains & Genetics
    • Autoflowers
    • Indoor Growing
    • Grow Equipment
    • Grow Journals
    • Grow Problems
    • Harvest, Dry & Cure
No Result
View All Result
My Cannabis Art
No Result
View All Result
Home News

DEA Faces Second Lawsuit From More Medical Marijuana Businesses That Say Rescheduling Rules Could Upend State Markets

by Spendog
November 22, 2026
in News
250 3
0
491
SHARES
1.4k
VIEWS
Share on FacebookShare on BlueskyShare on Threads

RelatedPosts

Closing the Gaps in Cannabis Dry-Room Handoffs

Closing the Gaps in Cannabis Dry-Room Handoffs

November 21, 2026
1.4k

New Mexico Officials Move To Ease Medical Psilocybin Rules Following Pushback

November 21, 2026
1.4k

Legalizing Marijuana In Wisconsin Can Save Hemp Business As Federal Policy Changes, Lawmakers Say

November 21, 2026
1.4k

A second group of medical cannabis businesses are suing the Drug Enforcement Administration (DEA) over restrictions the agency is placing on marijuana businesses in conjunction with the Trump administration’s federal rescheduling move that industry observers and regulators believe could upend state-licensed markets.

The latest challenge comes from four vertically integrated medical cannabis companies that say the DEA rules will prevent their dispensaries from selling products that their own cultivators grow.

Last month, DEA announced it had granted federal registration and protections to hundreds of medical marijuana businesses in line with rescheduling while also issuing new guidance warning that cannabis companies have until November 29 to begin sourcing product only from and to other operators that have also been granted or applied for registration in a timely fashion.

On Thursday, four companies that operate vertically integrated cultivation, processing and dispensary businesses in Pennsylvania filed a lawsuit asking the U.S. Court of Appeals for the District of Columbia Circuit to put a stay on the new DEA restrictions.

The companies—G.P.M.II, LLC, MLH Explorations LLC, Tri-Mountain Pure, LLC, and Story of PA CR, LLC—argue that DEA’s staggered rollout of forms to register medical marijuana dispensaries and manufacturers for federal protections caused “industry confusion” and ultimately did not give integrated businesses like theirs enough time or sufficient guidance to apply to receive expedited consideration of the cultivation divisions of their operations.

As a result of the recently issued DEA guidance, the companies’ dispensaries will not be able to sell the medical marijuana that their own cultivation employees are growing under state law, they say.

“Petitioners applied early—within 60 days of the rescheduling order—to register their dispensaries. They did not apply to register their manufacturing operations due to inconsistent and confusing direction from DEA. As a result, under new guidance issued by DEA on October 30, 2026, Petitioners’ manufacturing divisions will be barred from supplying any entity that is federally registered or that applied for registration during the 60-day window— including their own dispensaries—as of November 29, 2026.”

The DEA’s stance will “generate massive disruption by forcing early applicants (like Petitioners) to overhaul supply chains in a few short weeks, and shutting down facilities (like Petitioners’ manufacturing divisions) that lack early-applicant status,” the petition says. “Patients who rely on medical marijuana to treat chronic and debilitating conditions will bear the cost.”

Unless the court pauses the agency’s move within a matter of days, “the results will be devastating—for Petitioners’ businesses and reputations, for the many individuals they employ, and for the countless patients they serve,” the companies’ lawyers wrote.

“The counterparty restriction will upend Petitioners’ businesses. Their manufacturing arms stand to lose hundreds of thousands of dollars in monthly revenue from third-party-dispensary sales alone. And Petitioners’ dispensaries will be forced to buy from competitor manufacturers (if they are even able to locate sufficient supply)—or cease operations. Even if Petitioners somehow continue operating, they will be forced to take irreversible steps, including closing facilities and laying off employees.”

GPM is the parent company of the multi-state operator INSA, and Story’s parent company is Ascend Wellness Holdings, which also operates businesses in multiple states. MLH Explorations and Tri-Mountain Pure and their parent companies only operate in Pennsylvania.

A day earlier, the companies Standard Wellness Utah, Verde Americano in Arizona and NW Confections OK in Oklahoma brought a separate suit challenging the DEA medical cannabis guidance. The two cases have now been consolidated by the court and will be considered together.

The DEA’s guidance, the new Pennsylvania-focused petition argued, must be stayed because it is procedurally deficient, contrary to law and arbitrary and capricious.

“A later victory would come too late,” they said. “Even if DEA ultimately grants Petitioners federal registrations, the harm will be done.”

Among other claims, the petition says DEA failed to go through required notice and comment rulemaking for the new rules.

Meanwhile, DEA has been refusing to grant federal registration and protections to medical marijuana businesses in at least six states and Washington, D.C.

In orders to show cause sent to applicants in California, Delaware, the District of Columbia, Illinois, Minnesota, North Dakota and Oregon, the agency has cited various provisions of those states’ laws as reasons it cannot register any business within those jurisdictions.

Although the documents differ from state to state, there are similarities, according to industry sources who have reviewed the orders, the text of some of which have been shared with Marijuana Moment.

For example, the DEA orders generally cite some of the states’ allowance of businesses to sell non-medical marijuana as a violation of the Controlled Substances Act’s (CSA) “closed system” for medical access to scheduled drugs and of the U.S.’s international treaty obligations.

Some of the documents also single out state laws that allow certain patients to access medical cannabis without a doctor’s written recommendation.

State cannabis regulators have expressed frustrations with the agency’s actions and general refusal to communicate with them about its plans.

The Cannabis Regulators Association’s Gillian Schauer—who represents state officials across the U.S.—argued in a recent Marijuana Moment op-ed that the way DEA is implementing rescheduling has “created deep uncertainty and disruption for regulators, patients and market operators” and came with “little or no advance notice to state regulators and minimal communication afterward.”

“Supply chains in many states will not have enough cultivators, manufacturers and dispensaries to support a viable supply chain in either the DEA market or the state-only market,” she wrote. “With bifurcated and incomplete supply chains in states, some businesses will not survive in either market, patient access will be impacted, diversion and inversion will become more difficult for regulators to detect, health and safety compliance will be eroded and state revenues that support a variety of public services will decrease.”

Read the new lawsuit against the DEA below:

Photo elements courtesy of rawpixel and Philip Steffan.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!

Source link

Share196ShareShare

Related Posts

Closing the Gaps in Cannabis Dry-Room Handoffs

Closing the Gaps in Cannabis Dry-Room Handoffs

by Spendog
November 21, 2026
0
1.4k

An incorrect weight, unreadable container label, or missing inventory record may seem minor during a dry-room transfer, but unnoticed errors...

New Mexico Officials Move To Ease Medical Psilocybin Rules Following Pushback

New Mexico Officials Move To Ease Medical Psilocybin Rules Following Pushback

by Spendog
November 21, 2026
0
1.4k

“New Mexico is modeling how government, health experts, and community stakeholders can build something together.” By Jack Gorsline, Psychedelic State(s)...

Legalizing Marijuana In Wisconsin Can Save Hemp Business As Federal Policy Changes, Lawmakers Say

Legalizing Marijuana In Wisconsin Can Save Hemp Business As Federal Policy Changes, Lawmakers Say

by Spendog
November 21, 2026
0
1.4k

“Nobody who invested their money, who’s trying to make a legal living, should be forced to shut down just because...

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *


POPULAR

  • ILGM Beginner Mix cannabis seeds

    ILGM Beginner Mix: White Widow, AK-47 & Bubble Gum

    495 shares
    Share 198 Tweet 124
  • Granddaddy Purple Feminized Seeds: Genetics, Growing & Strain Guide

    494 shares
    Share 198 Tweet 124
  • Sour Diesel Feminized Seeds: Genetics, Growing & Strain Guide

    494 shares
    Share 198 Tweet 124
  • ILGM Autoflower 2.0 Mix: Bubblegum, Jack Herer & OG Kush Autos

    493 shares
    Share 197 Tweet 123
  • South Carolina Officials Are ‘Violating’ The Law By Not Allowing Medical Marijuana In Line With Federal Rescheduling, GOP Senator Says

    493 shares
    Share 197 Tweet 123

About Us

My Cannabis Art is an independent cannabis genetics and growing publication focused on seeds, strains, cultivation, and the science behind the plant. We aim to make cannabis information easier to understand through practical guides, genetics research, and honest product coverage for adults 21+.

Recent News

DEA Faces Second Lawsuit From More Medical Marijuana Businesses That Say Rescheduling Rules Could Upend State Markets

DEA Faces Second Lawsuit From More Medical Marijuana Businesses That Say Rescheduling Rules Could Upend State Markets

November 22, 2026
Closing the Gaps in Cannabis Dry-Room Handoffs

Closing the Gaps in Cannabis Dry-Room Handoffs

November 21, 2026

Category

  • Autoflower Seeds
  • Cannabis Knowledge
  • Feminized Seeds
  • Genetics & Science
  • Hybrid
  • Indica
  • Indoor Growing
  • Mix Packs
  • News
  • Outdoor Growing
  • Sativa
  • Seeds
  • Strains
  • About
  • Advertise
  • Privacy & Policy
  • Contact
  • Imprint
  • Cookie Policy
  • Privacy Statement
  • Cookie Policy (US)
  • Privacy Statement (US)
  • Cookie Policy (EU)
  • Privacy Statement (EU)
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (CA)
  • Privacy Statement (CA)

© 2026 My Cannabis Art. All rights reserved. Seeds, Genetics & the Art of Growing.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Google
Sign Up with Linked In
OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
My Cannabis Art
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
My Cannabis Art
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
No Result
View All Result
  • Home
    • Privacy Policy
    • About Us
    • Contact
    • Cookie Policy (CA)
    • Cookie Policy (EU)
    • Cookie Policy (UK)
    • Cookie Policy (US)
    • Privacy Statement (CA)
    • Privacy Statement (EU)
    • Privacy Statement (UK)
    • Privacy Statement (US)
    • Terms & Disclaimer
  • News
  • Cannabis Knowledge
  • Genetics & Science
  • Growing
  • Seeds
  • Strains

© 2026 My Cannabis Art. All rights reserved. Seeds, Genetics & the Art of Growing.

Are you 21 or older?

My Cannabis Art contains cannabis-related content intended for adults 21 and older. Please confirm your age to continue.

Yes, I’m 21 or Older
No, I’m Under 21